| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |